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Abstract
Background: Venezuela is an endemic area for human and canine leishmaniosis due to Leishmania infantum and
parasites of the Leishmania braziliensis and L. mexicana complexes. Limited data are available on feline leishmaniosis
(FeL) in this region. The aim of this study was to describe clinical and diagnostic aspects of FeL in Venezuela.
Results: Thirty-one domestic cats from urban areas of Lara State in Venezuela were enrolled. Twenty-five were healthy.
Six other cats had solitary or multiple nodular lesions, which were located on the nose, ears, tail and lower limbs.
Cutaneous lesions were characterized by diffuse pyogranulomatous infiltrate in all sick cats with numerous intracellular
and extracellular amastigotes, and immunohistochemistry was positive for Leishmania in five sick cats. All healthy cats
were seronegative for L. infantum and L. braziliensis antigens by ELISA. Two out of five sick cats yielded a positive ELISA
result to both Leishmania antigens with higher antibody levels to L. braziliensis compared to L. infantum. Significantly
higher antibody levels by ELISA as well as a higher number of bands by Western blot (WB) were found for L. braziliensis
when compared to L. infantum antigens in all sera from Venezuelan sick and healthy cats. All healthy cats were blood
Leishmania spp. qPCR negative while three out of six sick cats were blood qPCR positive. All paraffin-embedded skin
biopsies (n = 4) as well as cutaneous cytology (n = 3) were positive by Leishmania spp. qPCR in sick cats. Leishmania
speciation was obtained only from the cutaneous lesion samples from cytological preparations of two out of three sick
cats which were identified as infected with L. mexicana or a closely related specie.
Conclusions: Feline leishmaniosis should be included in the differential diagnosis list of nodular-ulcerative lesions. The
most reliable diagnostic technique in sick cats is cytological or histopathological examination along with
immunohistochemistry, since blood PCR and serology by ELISA might be negative. WB appears to be more sensitive in
detecting infection. Cats with leishmaniosis from Venezuela are most likely infected with species of L. mexicana or a
closely related species or the L. braziliensis species complex and not with L. infantum.
Keywords: Leishmania mexicana, Leishmania infantum, Leishmania braziliensis, Cats, Nodular-ulcerative lesions, ELISA,
qPCR, Immunohistochemistry, Venezuela
Background
Leishmaniosis is a parasitic disease caused by an obligate
intracellular protozoan of the genus Leishmania (Kineto-
plastida: Trypanosomatidae) [1]. In humans, it is mani-
fested clinically in multiple forms including the
cutaneous, mucosal and visceral leishmaniosis [2]. The
cutaneous form of leishmaniosis in the Eastern Hemi-
sphere is caused by Leishmania tropica, Leishmania
major and Leishmania aethiopica, as well as Leishmania
infantum and Leishmania donovani. The Leishmania
species found in America (the Western Hemisphere) are
either in the subgenus Leishmania represented by the L.
mexicana species complex (L. mexicana, L. amazonensis,
L. pifanoi, L. garnhami, L. aristidesi and L. venezuelensis)
or in the subgenus Viannia represented by the L. brazi-
liensis species complex [L. (V.) braziliensis, L. (V.) guya-
nensis, L. (V.) panamensis, and L. (V.) peruviana)] [3].
Cutaneous lesions are the most common clinical sign
of leishmaniosis both in human [4] and canine patients
[5] for certain Leishmania species such as L. infantum
and the L. mexicana and L. braziliensis species
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complexes. Over 200,000 people develop dermal and
mucosal leishmaniosis annually in Central and South
America [6, 7]. Venezuela is an endemic area of Ameri-
can human cutaneous leishmaniosis (ACL). A wide dis-
tribution of ACL has been observed, but the localized
clinical form tends to concentrate in states with moun-
tainous geography especially in the Andes (Trujillo, Mér-
ida, Lara and Táchira). It is interesting to note that Lara
and Mérida states are characterized by a fairly stable en-
demic situation that represents almost a third of all na-
tional cases [8]. Additionally, cutaneous lesions have
been reported in association with L. venezuelensis, in the
endemic focus of ACL both in humans and domestic an-
imals such as cats in Barquisimeto, Lara State, Venezuela
[9]. Moreover, description of human cutaneous leishma-
niosis caused by L. infantum is also documented [10].
However, Viannia is the most relevant subgenus in this
territory and is also responsible for metastatic hu-
man mucosal leishmaniosis, the severe form of tegumen-
tary disease [11, 12].
Feline leishmaniosis has been described with both
visceral and cutaneous forms by demonstration of the
presence of the parasite in cats. Several cases in domes-
tic cats have been globally reported, also in America and
especially in endemic areas of Central America [13],
South America such as Brazil [14, 15] and Paraguay [16]
and also in the Mediterranean basin [17] and the Middle
East [18]. Nonetheless, the real susceptibility of cats to
infection by Leishmania spp., their role as reservoir
hosts, and the outcome of leishmaniosis in these ani-
mals, are poorly understood [19]. Several Leishmania
species such as L. mexicana [20], L. venezuelensis [21],
L. braziliensis [22–24], L. amazonensis [25] and L. infan-
tum [15, 26–29] have been identified to infect cats in
Central and South America.
The most frequently described lesions in FeL are
ulcerocrusting, nodular dermatitis, alopecia and scaling
[30–32] while the visceral form of the disease involving
the spleen, liver, lymph nodes, bone marrow, eye and
kidney is less commonly diagnosed [33, 34]. Although
clinical cases of leishmaniosis have been reported in cats
with coinfection of feline leukemia virus (FeLV) and
feline immunodeficiency virus (FIV), the true association
between FeL and retroviral infections remains unclear
[32, 35].
The laboratory tests recommended for diagnosis of
FeL due to L. infantum include demonstration of the
presence of the parasite by direct microscopic examin-
ation in stained smears, and/or culture, serological tests
[indirect fluorescent antibody test (IFAT), enzyme-linked
immunosorbent assay (ELISA) and Western blot (WB)],
and molecular techniques such as the polymerase chain
reaction (PCR) [36]. However, limited information is
available regarding the diagnosis of other species of
Leishmania such as L. braziliensis infection in dogs and
cats [37].
Only very limited data are available on FeL in
Venezuela [9]. The identification of clinical manifesta-
tions associated with Leishmania spp. infection in
domestic cats in endemic areas as well as the best diag-
nostic techniques to be employed are crucial topics.
Therefore, the aim of this study was to describe clinical
and diagnostic aspects of FeL in an endemic area of
American cutaneous leishmaniosis, the state of Lara in
Venezuela.
Methods
Cats and sampling
Thirty-one outdoor domestic short hair cats from urban
areas (Barquisimeto, Cabudare, Quibor) of Venezuela
Lara State were enrolled. A full physical examination
was performed, and breed, age and gender were re-
corded before sampling. Twenty-five cats were appar-
ently healthy, and 6 cats presented cutaneous lesions.
Blood samples (n = 31) were collected into ethylenedi-
aminetetraacetic acid (EDTA) for DNA extraction and
quantitative PCR (qPCR) and into plain tubes to obtain
sera samples from 30 cats for Western blot (WB) and
enzyme-linked immunosorbent assay (ELISA) and stored
at -20 °C before use. Unfortunately, hematological and
biochemical profiles were not performed.
Diagnosis of Leishmania infection based on cytology,
histopathology and immunohistochemistry of cutaneous
lesions
Impression smears and fine needle aspirates from ulcera-
tive nodular lesions from 6 sick cats were sampled and
stained with a Romanowsky stain variant (Diff-Quick).
Macroscopical skin lesions of solitary or multiple nodu-
lar and ulcerative areas were biopsied in 5 cats. Skin
biopsies were fixed in 10% neutral buffered formalin.
The dermal inflammatory pattern and the cell popula-
tions were evaluated histologically in hematoxylin and
eosin (HE)-stained sections. A deparaffinization step was
performed on the paraffin blocks of skin biopsies before
Leishmania immunohistochemistry (IHC). Later, a
standard staining protocol with AutostainerPlus (Dako
Denmark A/S, Glostrup, Denmark) using rabbit poly-
clonal antibodies to L. infantum was followed. Sections
were then counterstained with hematoxylin and cover-
slipped for their interpretation [38].
Detection of antibodies against L. infantum and L.
braziliensis antigens by quantitative enzyme-linked im-
munosorbent assay (ELISA)
A Leishmania infantum in-house ELISA protocol previ-
ously described for cats [17] was slightly modified and L.
infantum (MHOM/MON-1/LEM 75) and L. braziliensis
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(MHOM/BR/88/BCN-25) antigens were used in the
same ELISA plate. Cat sera were diluted to 1:800 in
phosphate-buffered saline (PBS) with 0.05% Tween 20
(Sigma-Aldrich, St. Louis, Missouri, USA) containing
1% of dry milk and incubated in sonicated crude L.
infantum and L. braziliensis antigen-coated each in
half plates (20 μg/ml) for 1 h at 37 °C.
All plates included serum from a sick cat from Cyprus
with a confirmed infection with L. infantum as a positive
control [39] and serum from a healthy cat as a negative
control. All samples were analysed in duplicate. The re-
sult was quantified as ELISA units (EU) related to a
positive feline serum used as a calibrator and arbitrarily
set at 100 EU [40] for both antigens.
The cut-off for L. infantum was established at 9.2 EU
(mean + 4 SD of values from 80 cats from the UK, a
non-endemic area). Sera were classified as being positive,
when having a value equal or higher than 15.3 EU and
negative with 9.2 EU. Values in between were considered
doubtful.
The cut-off for L. braziliensis was established at 13.8
EU (mean + 4 SD of values from 80 cats from the UK, a
non-endemic area). Sera were classified as positive when
having a value equal or higher than 21.0 EU and negative
with 13.8 EU. Values in between were considered
doubtful.
Western blot (WB)
Sera from 25 apparently healthy cats and five cats
with lesions compatible with cutaneous leishmaniosis
from Lara State in Venezuela were assessed by WB.
In addition, sera from 8 cats from the Queen Mother
Hospital at the Royal Veterinary College (RVC), Uni-
versity of London, were used as negative controls
from cats living in a non-endemic area of leishmanio-
sis. Sera from 8 cats from Catalonia in Spain, of
which 6 cats were seropositive to L. infantum by
ELISA, one presenting a doubtful result and one
being negative, were also evaluated. Cats from Catalo-
nia (a non-endemic area for L. braziliensis infection)
were included to compare the pattern of WB with
cats from Venezuela. The seropositive cats to L.
infantum from Catalonia were diagnosed with clinical
leishmaniosis and used as positive controls for L.
infantum antigen.
Western blot was performed with L. infantum
(MHOM/MON-1/LEM 75) and L. braziliensis (MHOM/
BR/88/BCN-25) promastigotes as antigens [41, 42]. Sera
from cats with leishmaniosis that reacted with polypep-
tides of low molecular mass (< 36 kDa) of L. braziliensis
or L. infantum antigens were considered positive for WB
due to the fact that these antigens are the most specific
fractions in diagnosis of FeL [17, 43].
DNA extraction from blood, paraffin-embedded skin biop-
sies and cytology from skin lesions
Blood DNA purification
DNA was extracted using the Gen Elute blood genomic
DNA kit (Sigma-Aldrich) from 31 blood samples. Blood
from a non-infected clinically healthy cat was included
as negative control every time that DNA extraction was
performed [44].
Purification of genomic DNA from formalin-fixed, paraffin-
embedded skin biopsies
A deparaffinization step was performed on the paraf-
fin blocks of skin biopsies from 4 sick cats (FeV2,
FeV3, FeV5 and FeV6) using buffer (20 mM Tris-HCL
Ph 8.5; 1 mM EDTA), heating for 10 min at 95 °C
and centrifuging for 20 min at 12,000×g. Then, DNA
extraction was performed using the QIAamp® DNA
FFPE (Qiagen, Hilden, Germany) in accordance with
the manufacturer’s recommendations.
Purification of genomic DNA from cytological slides from
skin lesions
DNA extraction was performed from cutaneous lesions
from cytological slides from 3 sick cats (Fev3, Fev4 and
Fev5) with QIAamp® DNA Mini and Blood (Qiagen)
following the manufacturer’s instructions. A scalpel
(Braun, Tuttlingen, Germany) was used to obtain tissue
in a tube from each sample. Twenty microliters of prote-
ase, 200 μl of PBS and 200 μl of lysis buffer (Buffer AL)
were added and vortexed. Samples were incubated at 56
°C.
Leishmania spp. kinetoplast quantitative polymerase
chain reaction (qPCR)
The presence of Leishmania spp. DNA in blood samples
(n = 31), paraffin embedded skin biopsies (n = 4) and
cytological slides from cutaneous lesions (n = 3) was ini-
tially analysed by amplification of kinetoplast DNA
sequence by a real-time polymerase chain reaction
(qPCR). Each amplification was performed in triplicate,
in 20 μl reaction, 15 pmol of direct primer (5'-CTT TTC
TGG TCC TCC GGG TAG G-3'), 15 pmol of reverse
primer (5'-CCA CCC GGC CCT ATT TTA CAC CAA-
3'), 50 pmol of the labelled TaqMan probe (FAM-TTT
TCG CAG AAC GCC CCT ACC CGC-TAMRA) and 5
μl of sample DNA. Amplification and detection were
performed in the ABI Prism 7700 system (Applied
Biosystems, Foster City, CA, USA.) in two-step
temperature (94 °C and 55 °C) cycling over 45 cycles.
Positive controls (DNA from L. infantum MHOM /ES
/04 /BCN-61) and negative controls were included in
each RT-PCR analysis [45].
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Internal transcribed spacer 1 (ITS1) restriction fragment
length polymorphism (RFLP), quantitative PCR (qPCR),
sequencing and phylogenetic analysis
The species identification of the Leishmania isolates was
performed on DNA from cutaneous lesions (cytological
preparations) from 3 sick cats from Venezuela (FeV3,
FeV4 and FeV5) and on DNA from cutaneous lesions
(skin paraffin-embedded biopsies) from 4 sick cats (FeV2,
FeV3, FeV5 and FeV6). Two different techniques were
performed.
Polymerase chain reaction-restriction fragment length poly-
morphism (PCR-RFLP) analysis of amplified ITS-1 sequences
For the identification of Leishmania species, we ampli-
fied the ribosomal ITS-1 region with primers LITSR (5'-
CTG GAT CAT TTT CCG ATG-3') and L5.8S (5'-TGA
TAC CAC TTA TCG CAC TT-3') [46]. Amplification
reactions were performed in volumes of 50 μl containing
3 μl of isolated DNA, 5 μl of 10× buffer (BIOTAQ DNA
Polymerase, Bioline, London, UK), 1.5 mM MgCl2, 0.2
mM dNTP, 0.2 mM of each primer and 1.5 units of Taq
polymerase (BIOTAQ DNA Polymerase, Bioline). A de-
naturing step at 95 °C for 2 min, followed by 35 cycles
of denaturing for 20 s at 95 °C, annealing for 30 s at 53 °
C, and extension for 1 min at 72 °C, followed by a final
extension at 72 °C for 1 h was carried out in thermal cy-
cler (MJ Research PTC-200 DNA Engine, Alameda, CA,
USA). DNA samples extracted from promastigote cell
cultures of L. infantum, L. tropica, L. major and L. brazi-
liensis were used as positive controls. A non-template
control with the same reagents described above but
without DNA was added to PCR to rule out
contamination.
The PCR products, previously digested with the
restriction enzyme BsuRI (HaeIII), were separated by
electrophoresis in 2% wide-range agarose (Sigma) at 150
V in SGTB 1× buffer (GRISP LDA, Research Solutions,
Porto, Portugal). A solution of SYBR safe DNA gel stain
(Invitrogen Ltd., Paisley, UK) was used to visualize the
separated DNA fragments under UV light [47].
Quantitative PCR high-resolution melting (qPCR-HRM) Leish-
mania genotyping based on a ITS1, sequencing and phylo-
genetic analysis
A fragment of ITS1 region of the leishmanial ribosomal
RNA operon was amplified (265–288 bp) by real-time
PCR using primers ITS-219F (5'-AGC TGG ATC ATT
TTC CGA TG-3') and ITS-219R (5'-ATC GCG ACA
CGT TAT GTG AG-3') and then evaluated by high reso-
lution melting (HRM) analysis as previously reported
[48]. DNA samples extracted from promastigote cell cul-
tures of L. infantum, L. tropica and L. major were used
as positive controls for each corresponding PCR reaction
and DNA from colony-bred dogs negative by PCR for
vector-borne pathogens was used as a negative control.
A non-template control (NTC) with the same reagents
described above but without DNA was added to each
PCR to rule out contamination.
All positive PCR products were sequenced using the
BigDye Terminator v.3.1 Cycle Sequencing Kit and an
ABI PRISM 3100 Genetic Analyzer (Applied Biosystems),
at the Center for Genomic Technologies, Hebrew Univer-
sity of Jerusalem, Israel. DNA sequences were evaluated
with the ChromasPro software version 2.1.1 (Technely-
sium Pty Ltd., South Brisbane, Australia) and compared
for similarity with sequences available on the GenBank,
using BLAST program (https://blast.ncbi.nlm.nih.gov/
Blast.cgi).
Phylogenetic analysis was performed by MEGA6 [49]
using the Maximum Likelihood method based on the
Tamura 3-parameter model [50]. Initial phylogenetic
trees for the heuristic search were obtained by applying
the Neighbor-Joining method to a matrix of pairwise dis-
tances estimated using the Maximum Composite Likeli-
hood (MCL) approach. The bootstrap consensus tree
inferred from 1000 replicates was taken to represent the
evolutionary history of the taxa analyzed [51] and
branches corresponding to partitions reproduced in less
than 60% bootstrap replicates were collapsed.
Detection of FeLV antigen and FIV antibody
In order to evaluate retroviral infections to rule out con-
comitant infections the same 30 cats from Venezuela de-
scribed above (5 sick cats and 25 apparently healthy
cats) were tested serologically for FeLV antigen and FIV
antibody. Detection of FeLV p27 antigen and anti-FIV
antibodies was performed by a commercial ELISA
(INGEZIM FeLV and INGEZIM FIV®, Ingenasa, Madrid,
Spain) according to the manufacturer’s protocol.
Statistical analysis
Statistical analysis was performed using the SPSS 17.0
software for Windows (SPSS Inc., Chicago, USA). A
non-parametric Mann-Whitney U-test was used to com-
pare groups. A non-parametric Wilcoxon signed-rank
test was used to compare paired continuous variables.
Differences were considered significant with a 5% signifi-
cance level (P < 0.05. The descriptive statistical analysis
was conducted with R project software (2017).
Results
Cats
Physical examination of all cats included in this study
determined that 24 were adults, 5 were old cats and 2
were young cats. Moreover, the distribution according to
gender was 13 females and 18 males. The majority of
cats did not present any systemic clinical sign or derma-
tological lesions compatible with leishmaniosis and were
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classified as apparently healthy (25/31, 80.6%). All appar-
ently healthy cats were owned cats from Barquisimeto
and Cabudare cities from Lara State. They were 9 fe-
males (n = 2, old cats; n = 7, adults) and 16 males (n =
3, old cats; n = 12, adults; and n = 1 young cat). On the
other hand, 6 of the 31 cats (6/31, 19.3%) presented der-
matological clinical signs. Signalment, geographical loca-
tion and clinical description are summarized in Table 1.
Sick cats were all stray cats living in cat colonies. They
were 4 females and 2 males all adults, except for one 8-
month-old young male. Skin lesions consisted of solitary
or multiple nodular lesions (Fig. 1) which were located
on the nose (n = 3) (Fig. 1d-f ); ears (n = 1) (Fig. 1c); ears
and nose (n = 1) (Fig. 1a, b); and nose, ears, tail and
lower limbs (n = 1). Cats did not show other clinical
signs. Those cats did not receive any treatment and were
humanely euthanized.
Cytology, histopathology and immunohistochemistry
Cytology was performed from cutaneous lesions in 4
sick cats. In the majority of cases, mixed inflammation
with predominance of macrophages and neutrophils was
found. Numerous intracellullar and extracellular Leish-
mania amastigotes were also noted (Fig. 2a, b). Histolog-
ically, cutaneous lesions from 4 sick cats were
characterized by epidermal hyperplasia and hyperkera-
tosis. Diffuse infiltrate with predominance of macro-
phages and plasma cells with numerous intracellular and
extracellular amastigotes were observed (Fig. 2c). Occa-
sionally, mast cells, lymphocytes and eosinophils were
also encountered. Additionally, one sick cat presented
crusting and necrosis, and presence of amastigotes was
not observed. Immunohistochemistry was positive for
Leishmania spp. in the 5 biopsied cats (Fig. 2d).
ELISA
All apparently healthy cats (n = 25) were negative by
ELISA for L. braziliensis (mean ± SD = 4.5 ± 2.6 EU)
and most of them (n = 22) were negative for L. infantum
(mean ± SD = 2.5 ± 1.5 EU) antigens. Interestingly,
when all sera samples (n = 30) were analysed, statisti-
cally significant higher antibody levels were found for L.
braziliensis (mean ± SD = 7.0 ± 9.8 EU) when compared
to L. infantum (mean ± SD = 4.5 ± 7.6 EU) antigen
(Wilcoxon signed-rank test: Z = -4.679, P < 0.0001).
Additionally, 3 out of 25 apparently healthy cats and one
sick cat presented doubtful results for L. infantum anti-
gen. There were no animals with doubtful results for L.
braziliensis antigen. Specific antibody response was sig-
nificantly higher in sick cats when compared to healthy
cats to both L. braziliensis (Mann-Whitney U-test: Z
= -2.47, P = 0.01) and L. infantum (Mann-Whitney U-
test: Z = -2.69, P = 0.05) antigens. Two out of 5 sick cats
yielded positive ELISA result to both Leishmania
antigens (L. infantum: mean ± SD = 30.2 ± 10.9 EU and
L. braziliensis: mean ± SD = 39.9 ± 17.9 EU) while the
rest were seronegative (Table 1). Also, higher antibody
levels were found for L. braziliensis (mean ± SD = 19.9
± 20.3 EU) antigen than to L. infantum (mean ± SD =
14.7 ± 15.2 EU) antigen when all sick cats were evalu-
ated for ELISA (Wilcoxon signed-rank test: Z = -2.023, P
= 0.043).
The cats that were seropositive to L. infantum antigen
from Catalonia were diagnosed with clinical leishmanio-
sis. When those animals were tested serologically with L.
braziliensis antigen, 5 out of 8 presented negative ELISA
results, one had a doubtful result and two showed posi-
tive results.
Western blot
As expected, sera from cats from the UK did not
react with any polypeptides from both antigens. Bands
recognized for L. braziliensis and L. infantum anti-
gens by cat sera from Venezuela and Catalonia are
described in Table 2. In the case of the Venezuelan
samples, the highest sensitivity for L. braziliensis anti-
gen was found in the following fractions: 70, 65, 52,
50, 46, 42, 36, 34, 30, 28, 18 and 16 kDa. The highest
sensitivity for L. infantum antigen in Venezuelan cats
was found in the following fractions: 70, 65, 46, 34,
30, 28, 24, 18 and 16 kDa (Table 2). In contrast,
Catalonian samples recognized a higher number of
bands for L. infantum antigen (70, 65, 52, 46, 28, 24,
20, 18, 16 and 14 kDa) when compared to L. brazi-
liensis antigen (70, 68, 65, 16 and 14 kDa).
The majority of sick cat sera from Venezuela recog-
nized variable patterns of polypeptides with molecular
masses ranging between 14–70 kDa for L. braziliensis
antigen while they recognized polypeptide from L. infan-
tum antigen less frequently (Table 1).
There was a statistically significant predominance of
bands specific for L. braziliensis antigen in cats from
Venezuela when compared to Catalonian cats (Table
2) (Mann-Whitney U-test: Z = -4.03, P = 0.0001). Also,
when sick Venezuelan cats were compared to sero-
positive cats from Catalonia, a high number of bands
for L. braziliensis antigen was observed (Mann-Whit-
ney U-test: Z = -2.55, P = 0.01) (Table 3).
The Venezuelan cats showed a significantly higher
number of bands for L. braziliensis antigen when com-
pared to L. infantum antigen (Wilcoxon signed-rank
test: Z = -3.15, P = 0.02) (Table 2). Additionally, a higher
number of bands for L. brazilienis antigen were also
found when compared with L. infantum antigen in
Venezuelan sick cats (Wilcoxon signed-rank test: Z
= -3.58, P = 0.0001) (Table 3). No statistical differences
were observed within Catalonian cats when L. brazilien-
sis and L. infantum bands were compared.
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Four out of five sick cats from Venezuela resulted posi-
tive for L. braziliensis [low molecular mass (< 36 kDa)]. In
addition, positive results to L. braziliensis WB were found
in 6 out of 25 (24%) apparently healthy cats from
Venezuela and also in 2 sick cats from Catalonia. In the
case of cats from Venezuela, 3 sick cats and 7 apparently
healthy cats resulted positive for L. infantum WB. Five out
of eight Catalonian cats presented compatible results for
L. infantum antigens. In general, the intensity of bands in
sick cats increased with an increase in the antibody level.
Fig. 1 Cats with cutaneous leishmaniosis: a Adult female cat with ulcerative nodular lesions in the nose, front leg and pinna (ID: FeV2). b Close
up of the same cat (ID: FeV2). c Adult female cat, ulcerative lesion in the pinna (ID: FeV4). d Adult female cat with a nasal ulcer (ID: FeV6). e Adult
female cat with an ulcerative nodular lesion on the nose (ID: FeV5); f 8-month-old male cat with an ulcerated nodule on the nose (ID: FeV3)
Fig. 2 a, b Cytology from cutaneous lesions from cat ID Fev3 with macrophagic-neutrophilic inflammation, showing numerous intracellular and
extracellular Leishmania amastigotes (arrows) (diff quick stain 1000×). Scale-bars: 10 μm. c Diffuse pyogranulomatous inflammatory infiltrate from
cat ID Fev5 with numerous Leishmania amastigotes (arrows) (H&E 400×). d Positive immunohistochemistry for Leishmania amastigotes from cat ID
Fev5 (brown dots are indicated with arrows) (400×). Scale-bars: 50 μm
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Blood and cutaneous lesions Leishmania kinetoplast
qPCR, ITS1 RFLP and qPCR for identification, sequencing
and phylogenetic analysis
All twenty-five clinically healthy cats were blood qPCR
negative (25/31 cats, 90.3%). Additionally, when blood
from sick cats was analysed, 3 out of 6 cats were Leish-
mania kinetoplast qPCR positive (3/31 cats, 9.7%) while
3 were negative, including 1 seropositive sick cat by
ELISA. DNA extraction was performed from paraffin-
embedded skin biopsies of 4 sick cats and all samples
were positive by kinetoplast qPCR (Table 1). There was
no correlation between the pattern of bands recognized
by WB and PCR results.
DNA samples from cytological preparations of cutane-
ous lesions from 3 cats was extracted and all samples
were positive by kinetoplast qPCR (Table 1). Positive
DNA samples from cutaneous lesions paraffin-
embedded skin biopsies (n = 4) and cytological prepara-
tions (n = 3)] were submitted to parasite species identifi-
cation by PCR amplifying a fragment of the ITS1 region.
Only samples from cytological preparations of 2 cats
were positive by ITS1 qPCR-HRM (FeV3 and FeV4)
while samples from FeV5 were negative. In addition, the
same DNA from the cytological preparation from FeV3
was also confirmed as positive by PCR-RFLP, but FeV4
and FeV5 were PCR-RFLP-negative (Table 1). All DNA
samples from paraffin-embedded skin biopsies were
negative by ITS1 qPCR-HRM (Table 1) and PCR-RFLP.
The DNA sequence of cat FeV3 was 100% identical to a
partial 18S rRNA ITS1 sequence of L. mexicana (Gen-
Bank: AB558250.1) over 210 bp, as found by BLAST
analysis. In contrast, the DNA sequence of cat FeV4 was
Table 2 Antibody recognition of L. infantum and L. braziliensis antigens by WB in sera of cats from Venezuela and Catalonia (Spain)
WB band (kDa) Leishmania braziliensis antigen Leishmania infantum antigen
Total no. of cats
(n = 38)
Endemic area
Catalonia (n = 8)
Endemic area
Venezuela (n = 30)
Total no. of cats
(n = 38)
Endemic area
Catalonia (n = 8)
Endemic area
Venezuela (n = 30)
n % n % n % n % n % n %
70 11 12 2 10 9 13 5 9 1 4 4 11
68 2 2 2 10 2 3 0 0 0 0 0 0
65 7 8 2 10 5 7 3 5 1 4 3 8
58 1 1 0 0 1 1 0 0 0 0 0 0
56 2 2 0 0 2 3 0 0 0 0 0 0
52 5 5 0 0 5 7 1 2 1 4 0 0
50 3 3 0 0 3 4 0 0 0 0 0 0
48 2 2 0 0 2 3 0 0 0 0 0 0
46 6 7 1 5 5 7 3 5 1 4 2 6
44 2 2 2 10 0 0 1 2 0 0 1 3
42 2 2 0 0 2 3 0 0 0 0 0 0
40 1 1 1 5 0 0 0 0 0 0 0 0
38 1 1 0 0 1 1 0 0 0 0 0 0
36 3 3 1 5 2 3 0 0 0 0 0 0
34 4 4 1 5 3 4 7 12 3 13 4 11
30 6 7 1 5 5 7 5 9 3 13 2 6
28 7 8 1 5 6 8 6 10 1 4 5 14
24 3 3 1 5 2 3 5 9 2 9 3 8
22 1 1 0 0 1 1 0 0 0 0 0 0
20 3 3 0 0 3 4 3 5 2 9 1 3
18 6 7 1 5 5 7 5 9 2 9 3 8
16 8 9 2 10 4 6 11 19 4 17 7 19
14 5 5 2 10 3 4 3 5 2 9 1 3
Total no.
of bands
91 20 71 58 23 36
Mean no.
of bands
3.9 0.8 3.0 2.5 1.5 1
Note: Statistical results: L. braziliensis bands: Venezuelan cats > Catalonian cats (Mann-Whitney U-test: Z = -4.03, P = 0.0001). Venezuelan cats: L. braziliensis > L.
infantum (Wilcoxon signed-rank test: Z = -3.15, P = 0.02)
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only 93% identical to a partial 18S rRNA ITS1 sequence
of L. mexicana (GenBank: AB558250.1). A phylogenetic
tree with the two Venezuelan cats’ results is presented
in Fig. 3; in this tree, the DNA sequences from cats
FeV3 and FeV4 clustered together with L. mexicana se-
quences from other sources deposited in GenBank.
Detection of FeLV antigen and FIV antibodies and
relationship with Leishmania infection
All cats tested (n = 30) were negative for FeLV antigene-
mia. FIV-specific antibodies were found in 2 out of 25
apparently healthy cats tested (6.6%), both of them sero-
negative for L. infantum and L. braziliensis-specific anti-
bodies based on ELISA and also negative by kinetoplast
qPCR, but when WB positivity was studied, both cats re-
sulted positive to L. braziliensis-specific bands and one
was positive to L. infantum-specific bands.
Discussion
The present study describes a clinical case series of soli-
tary or multiple ulcerative nodular dermatitis due to
Leishmania spp. in cats from Lara State, Venezuela. Un-
fortunately, so far, Leishmania identification has only
been possible from the skin lesion of two cats and iden-
tified as L. mexicana. To the best knowledge of the au-
thors, we report the first feline case of cutaneous lesions
due to L. mexicana infection from Lara State, Venezuela.
Interestingly, so far cats have only been described to be
Table 3 Antibody recognition of L. braziliensis and L. infantum antigens by WB in seropositive and sick cats from Venezuela and
Catalonia (Spain)
WB band
(kDa)
Leishmania braziliensis antigen Leishmania infantum antigen
Total no. of
cats (n = 10)
Endemic area
Catalonia (n = 5)
Endemic area
Venezuela (n = 5)
Total no. of cats
(n = 10)
Endemic area
Catalonia (n = 5)
Endemic area
Venezuela
(n = 5)
n % n % n % n % n % n %
70 5 9 2 10 3 8 3 8 1 0 2 13
68 3 5 2 10 1 3 0 0 0 0 0 0
65 4 7 2 10 2 6 3 8 1 0 2 13
58 1 2 0 0 1 3 0 0 0 0 0 0
56 1 2 0 0 1 3 0 0 0 0 0 0
52 1 2 0 0 1 3 1 3 1 0 0 0
50 1 2 0 0 1 3 0 0 0 0 0 0
48 1 2 0 0 1 3 0 0 0 0 0 0
46 3 5 1 5 2 6 3 8 1 0 2 13
44 2 4 2 10 0 0 1 3 0 0 1 7
42 2 4 0 0 2 6 0 0 0 0 0 0
40 1 2 1 5 0 0 0 0 0 0 0 0
38 1 2 0 0 1 3 0 0 0 0 0 0
36 3 5 1 5 2 6 0 0 0 0 0 0
34 3 5 1 5 2 6 3 8 3 1 0 0
30 3 5 1 5 2 6 4 11 3 1 1 7
28 4 7 1 5 3 8 4 11 1 0 3 20
24 3 5 1 5 2 6 3 8 2 0 1 7
22 1 2 0 0 1 3 0 0 0 0 0 0
20 1 2 0 0 1 3 3 8 2 0 1 7
18 4 7 1 5 3 8 3 8 2 0 1 7
16 4 7 2 10 2 6 5 13 4 1 1 7
14 4 7 2 10 2 6 2 5 2 0 0 0
Total no.
of bands
56 20 36 38 23 15
Mean no.
of bands
2 1 2 2 1 1 2
Note: Statistical results: L. braziliensis-specific bands: Venezuelan sick cats > Catalonian sick cats (Mann-Whitney U-test: Z = -2.55, P = 0.011). Venezuelan sick cats: L.
braziliensis > L. infantum (Wilcoxon signed-rank test: Z = -3.58, P =0.0001)
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infected with L. mexicana in Texas in the USA [13, 20,
52]. In agreement with our findings, L. mexicana infec-
tion was previously diagnosed in humans with cutaneous
leishmaniosis from Lara State, Venezuela [53] as well as
in pools of Lutzomyia sand flies from Sucre State in
Venezuela [54].
Unfortunately, Leishmania identification was not
obtained from the remaining sick cats from Venezuela
described in the present study. Since formalin-fixation of
histological specimens causes partial DNA destruction,
which may hamper diagnostic PCR analysis [55, 56], we
believe that there was inhibition of DNA PCR-based
analyses of histological specimens. Therefore, the
amount of DNA amplified was reduced and this did not
enable the identification of Leishmania. However, based
on clinical and serological findings and the geographical
distribution of FeL [36], it is likely that species of L.
mexicana and/or L. braziliensis complexes were the
cause of infection of the remaining cats described here.
As with the cases presented here, clinical disease in cats
caused by natural infection with species other than L.
infantum is typically reported as nodular or ulcerative
dermatitis with no systemic clinical signs. Skin lesions
are often single but they can metastasize [36].
Solitary cutaneous lesions have been reported in asso-
ciation with L. venezuelensis infection, in the endemic
focus of ACL both in humans and domestic animals in
Barquisimeto, Lara State, Venezuela [9, 53]. Interestingly,
in this previous study, four cats were observed with
cutaneous nodules on the nose and smaller nodules on
the ears, and diffuse nodular lesions on the tail and legs
[9]. This clinical presentation was similar with the find-
ings obtained in the present study from cats from the
cities of Quíbor, Cabudare and Barquisimeto in Lara
State, Venezuela. It is also important to highlight that
feline cutaneous lesions described in the present study
are similar to the ones described also in humans. It is
likely that cats might only be an accidental host of L.
venezuelensis infection [36]. It is also important to
remark that the grouping of L. mexicana species com-
plex is still controversial [53]. Leishmania venezuelensis
was originally described on the basis of distinguishable
multilocus enzyme electrophoresis (MLEE) patterns as a
species independent of other members of the L. mexi-
cana complex [57]. Furthermore, a monoclonal antibody
specific for L. venezuelensis was developed for identifica-
tion using immunological methods [58]. However, there
are limited molecular data regarding L. venezuelensis
[59] and some authors strongly suggested that L. vene-
zuelensis is a variant of L. mexicana [53].
A study carried out in Cojedes State of Venezuela
revealed human, dog and equine populations with ul-
cers, other active lesions, skin scars and mucosal alter-
ations, due to Leishmania (Viannia) braziliensis
characterized by zymodeme and serodeme typing [60].
In addition, natural [23, 24] and experimental [19] L.
Fig. 3 Phylogenetic analysis constructed based on 210 bp DNA sequences of the ITS1 locus of Venezuelan cats (FeV3 and FeV4). Sequences from
this study were compared to other sequences deposited in GenBank. Phylogenetic analysis was inferred by using the Maximum Likelihood
method based on the Tamura 3-parameter model. The number of bootstrap replicates are 1000 and branches corresponding to less than 60%
bootstrap replicates are collapsed. Bootstrap values higher than 60% are indicated next to the branches. GenBank accession number, the strain,
country of origin and host from which the sequences were derived are included for each sequence
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braziliensis infections have been described in domestic
cats. Leishmania braziliensis natural infection in cats has
been described in Brazil [60], French Guiana [23] and in
northern Argentina [61]. Cutaneous lesions previously
described were also similar to the ones reported in the
present study. However, the finding of cats with cutane-
ous leishmaniosis does not reflect an important role of
these domestic animals in the natural transmission of
the disease in these areas, and these animals probably
represent accidental hosts [21].
In the present study, cats presented ulcerative nodular
dermatitis mainly on the face. Cutaneous lesions in cats
naturally infected with Leishmania spp. occur mainly on
the nose, followed by the ears or at both sites [2] and
also occasionally on the limbs. The skin alterations in
FeL are unspecific and can be associated with other clin-
ical conditions [25]. The commonly seen cutaneous
nodular form in FeL cases should be distinguished from
nodules caused in cats with sterile or eosinophilic granu-
loma, cryptococcosis, sporotrichosis, histoplasmosis,
mycobacterioses, and a wide variety of cutaneous neo-
plasms, e.g. feline sarcoids, mast cell tumor, fibrosar-
coma, basal cell carcinoma, bowenoid in situ carcinoma
and lymphoma [36]. The main differentials of the ulcera-
tive lesions include squamous cell carcinoma, idiopathic
ulcerative dermatitis, herpes virus dermatitis, mosquito-
bite dermatitis, atypical mycobacteriosis and feline
leprosy, cutaneous vasculitis, erythema multiforme and
cold-agglutinin disease. Interestingly, squamous cell
carcinoma may co-exist with Leishmania infections as
clinical case reports due to L. infantum have been docu-
mented in cats in Europe [62, 63]. In the present study,
concomitant disease was not diagnosed in the sick cats
studied.
Leishmaniosis is diagnosed by demonstration of the
parasite by direct microscopic examination in stained
smears, and/or culture of skin lesions, lymph node
aspirates, peripheral blood, bone marrow aspirates or
indirectly by serological techniques [41]. A clinical
form characterized by a very low number of intrale-
sional parasites can be detected by an immunohisto-
chemical technique. This technique is a highly
sensitive and specific tool for the diagnosis of canine
and feline leishmaniosis [36, 64]. In this study, differ-
ent techniques were used in the cats with cutaneous
lesions, such as cytology, skin biopsy and immunohis-
tochemistry, by which the diagnosis of infection by
Leishmania spp. was made. Besides that, serological
and molecular diagnostic techniques were also used
in sick and apparently healthy cats. One sick cat and
25 clinically healthy cats were negative by serology
and blood qPCR. The sick cats did not always give a
positive result to blood qPCR and serology. The
present findings might indicate that clinically healthy
cats are not carriers of Leishmania spp. present in
Venezuela.
Moreover, the ELISA and qPCR discordant results can
be attributed to the inherent differences between sero-
logical testing and molecular methods. PCR is a very
sensitive technique. However, intermittent parasitemias
are very likely in cats as described in dogs [65] and
therefore, PCR from blood might not be very sensitive.
The parasite load in blood was quite variable in the cats
studied and poorly correlated with the degree of anti-
body levels [17]. The present findings suggest that more
than one technique should be used for detection of fe-
line cutaneous leishmaniosis in South America.
Leishmania species such as L. infantum and L. brazi-
liensis among others co-exist in South America and both
species can infect cats [36]. However, there are limited
studies regarding serological tests that will distinguish
between L. infantum- and L. braziliensis-specific feline
antibodies in these regions. Here, we report an ELISA
that combines both antigens. Interestingly, higher anti-
body levels were found using L. braziliensis antigen in
Venezuelan cats when compared with L. infantum anti-
gen. This quantitative in-house ELISA appears to help
establishing what Leishmania species or closely related
Leishmania species are most likely infecting cats in the
respective endemic areas. These findings are extremely
important in areas where several parasite species might
co-exist, therefore, this type of ELISA should be used to
determine the most likely Leishmania parasite infecting
dogs and cats in South America. Unfortunately, we did
not have antigen of L. mexicana to perform WB.
Furthermore, the WB analysis also revealed that Vene-
zuelan cat sera recognized a significantly higher number
of L. braziliensis polypeptides when compared to L.
infantum antigen. In addition, the intensity of bands in-
creased with an increase in the antibody level. There
was no correlation between the pattern of bands recog-
nized and PCR results. Antigens of low molecular weight
(12–14 and 14–18 kDa), seem to be very specific and
their recognition in the immunoblot is highly sensitive
in the diagnosis of subclinical Leishmania infection in
dogs and cats [43]. In the cats analysed, similar results
were observed. In experimentally infected dogs, anti-
bodies specific for low molecular weight fractions are
the first to appear following infection [41]. Based on the
results of this study, it appears that the WB enables
detection of early phases of infection in apparently
healthy cats with negative antibody levels by ELISA or
PCR results. It also important to highlight that WB
seems to be the best serological technique to be used
when testing sick and apparently healthy cats from
Venezuela as previously reported for European cats [43].
In agreement with the present study, another study
reveals that the use of WB with whole antigen or
Rivas et al. Parasites & Vectors  (2018) 11:141 Page 11 of 14
antigenic Fe-SODe (iron superoxide dismutase) fraction
was an optimal method for the detection of FeL [66].
The use of antigenic fractions of cultures of L. mexicana,
L. braziliensis and L. infantum showed satisfactory
results with high sensitivity, specificity and efficacy for
the detection of this disease in cats [66]. Therefore, WB
should be widely used in the clinical setting for diagnosis
clinical FeL as well as for detection of subclinical
infections.
Conclusions
We conclude that leishmaniosis should be included in
the differential diagnosis list of nodular-ulcerative lesions
in cats, mainly on the nose and ears. In addition, to the
best of our knowledge, we described for the first time,
cutaneous lesion associated with L. mexicana infection
from two Venezuelan cats. The most reliable diagnostic
technique in sick cats is cytological or histopathological
examination along with immunohistochemistry, since
blood PCR and serology by ELISA might be negative.
However, WB appears to be more sensitive in detecting
infected cats. Based on molecular and serological find-
ings, cats from Venezuela are most likely infected with
species of L. mexicana or L. braziliensis species com-
plexes rather than L. infantum. Finally, the present find-
ings might indicate that clinically healthy cats are not
carriers of Leishmania spp. present in Venezuela.
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